FRZB and renal carcinoma: Vessel dilator decreased the sFRP-3 level in the human renal cancer cells by 68% at a concentration of 1 μM (P<0.0001), and KP maximally reduced the sFRP-3 level by 66% (P<0.0001) at the same concentration.